Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Day One Biopharmaceuticals (DAWN) Accumulated Depreciation & Amortization: 2022-2023

Historic Accumulated Depreciation & Amortization for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2023 value amounting to $30,000.

  • Day One Biopharmaceuticals' Accumulated Depreciation & Amortization fell 63.86% to $30,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $66,000, marking a year-over-year change of. This contributed to the annual value of $6,000 for FY2022, which is N/A change from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $30,000 for Q3 2023, which was up 66.67% from $18,000 recorded in Q2 2023.
  • Day One Biopharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $83,000 for Q3 2022, and its period low was $6,000 during Q4 2022.
  • Its 2-year average for Accumulated Depreciation & Amortization is $33,857, with a median of $30,000 in 2023.
  • Data for Day One Biopharmaceuticals' Accumulated Depreciation & Amortization shows a maximum YoY plummeted of 70.73% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Day One Biopharmaceuticals' Accumulated Depreciation & Amortization stood at $6,000 in 2022, then crashed by 63.86% to $30,000 in 2023.
  • Its Accumulated Depreciation & Amortization was $30,000 in Q3 2023, compared to $18,000 in Q2 2023 and $12,000 in Q1 2023.